In this episode, Max Williamson, a Patient Representative for the UK National Cancer Research Institute, and Karen Rowland Yeo, PhD, Senior Vice President at Certara, discuss the challenges in pediatric drug development, including accessibility issues for young people and the need for more qualitative data. Max and Karen also talk about how technology can accelerate getting new medicines to children as well as emerging trends in the space over the next 5 years.
This podcast is sponsored by Certara.
